Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

ORACLE

Financiado

Origins of Alzheimer s disease across the life course

The origins of Alzheimer’s disease (AD) remain elusive. The long pre-clinical phase of AD is universally recognized, but it is not known when predisposition for AD develops nor when the first signs and symptoms become discernable.... ver más

28/02/2022

ERASMUS MC

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDA... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-02-28

ERC-StG-2015: ERC Starting Grant

I+D

Cerrada hace 9 años

0% 100% 100%

2 Participantes

ERASMUS MC

1.50M€ | Lider

AES

1.47M€ | Participante

Proyectos interesantes

PID2019-107286RB-I00 PAPEL DEL ANTAGONISTA DE RECEPTORES DE MUERTE, FAIM-L EN LA... 167K€ Cerrado

PID2020-113878RB-I00 EFECTO DEL ENVEJECIMIENTO Y LA NEURODEGENERACION EN EL COMPO... 242K€ Cerrado

RYC-2010-05627 Molecular basis of cognitive impairment in Alzheimer¿s disea... 192K€ Cerrado

RYC-2017-21879 Risk factors for Alzheimer's disease. Effect on neuropatholo... 309K€ Cerrado

RTC-2017-6424-1 Nuevos alimentos para prevención de enfermedades con deterio... 374K€ Cerrado

PSI2017-89389-C2-2-R ESTUDIO LONGITUDINAL DEL DETERIORO COGNITIVO EN EL DCL Y EA... 109K€ Cerrado

Últimas noticias

02-12-2024: AGENCIA-VALENCIANA-D... En las últimas 48 horas el Organismo AGENCIA VALENCIANA D... ha otorgado 1 concesiones

02-12-2024: CDTI En las últimas 48 horas el Organismo CDTI ha otorgado 4 concesiones

01-12-2024: REDES En las últimas 48 horas el Organismo REDES ha otorgado 1337 concesiones

Duración del proyecto: 68 meses Fecha Inicio: 2016-06-07
Fecha Fin: 2022-02-28

Presupuesto del proyecto 1M€

Descripción del proyecto The origins of Alzheimer’s disease (AD) remain elusive. The long pre-clinical phase of AD is universally recognized, but it is not known when predisposition for AD develops nor when the first signs and symptoms become discernable. In this regard, an essential role is played by the ‘reserve’ capacity of the brain, which is built up in early life and acts as buffer against adverse risk factors later in life. However, life-time trajectories of build up and loss of reserve and its determinants remain poorly understood. In ORACLE, I aim to unravel the origins of AD by studying reserve across the entire life-span: from in utero to end of life. The underlying hypothesis is that etiologic factors exert their effect on the risk of AD during the entire life-span, through build-up and loss of reserve. Such life-course approach to study reserve is worldwide unique and constitutes truly ground-breaking research aimed at unraveling the earliest origins of AD. Key objectives are: 1) To study trajectories of reserve across the entire lifespan. 2) To study factors that shape reserve in early life. 3) To study factors that determine onset and early loss of reserve. I will compile a life-course cohort that consists of three population-based samples totalling 40,829 persons that together cover the entire life-span: children in Generation R Study (in utero – 18 yrs); parents in Generation R Study (18–45 yrs); and the Rotterdam Study (45 yrs – death). Reserve will be quantified structurally using imaging techniques that measure volumetry, perfusion and connectivity as well as functionally by measuring cognitive and non-cognitive brain functions. I will study genetic and non-genetic risk factors of AD and their effects on reserve. Results from ORACLE will provide ground-breaking new insights into the earliest origins of AD. In turn, these insights are of major importance to enable the early identification of persons at highest risk of AD and develop targeted prevention for these persons.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores